期刊文献+

中药有效成分辨识的研究进展 被引量:2

Research Progress on Identification of Active Ingredients in Traditional Chinese Medicines
下载PDF
导出
摘要 目的为明确中药作用功效,有效地从中药复方化合物中发现和辨识出起作用的有效成分。方法检索和总结相关文献,提炼中药有效成分辨识的相关思路。结果以中医理论指导和以生物体内代谢过程进行的中药有效成分辨识为主要研究思路。结论中药有效成分辨识的这2个研究思路皆有优势及不完善之处,科学地将两者结合可达到互补作用。 Objective To effectively find and identify the clarify the active ingredients in traditional Chinese medicine compounds so as to definite the effects of traditional Chinese medicines. Methods The relevant literatures were retrieval and summarized for extracting and purifying the related ideas identifyign the effective ingredients in traditional Chinese medicines. Results Conducting the identifica- tion of the active ingreedients of traditional Chinese medicines by the Chinese medicine theory as the guidance and the in vivo bio- logical metablic process are the two main research ideas. Conclusion Both the reserach ideas of the identification of the active ingre- dients of traditional Chinese medicines have the superiority and the imperfection, the scientific combination of the two can achieve the complementary roles.
作者 李花 陈玉文
出处 《中国药业》 CAS 2014年第5期3-6,共4页 China Pharmaceuticals
基金 科技部"十二五"重大新药创制国家科技重大专项"辽宁省国家重大新药创制综合平台--基于信息管理的新药研发风险控制技术"资助项目 项目编号:2013ZX09301305
关键词 有效成分 研究方法 体内代谢 中医理论 active ingredients research methods in vivo metabolism Chinese medicine theory
  • 相关文献

参考文献22

二级参考文献144

共引文献617

同被引文献34

  • 1李芸霞,彭成.中药口服吸收屏障研究方法[J].中药与临床,2010,1(3):55-58. 被引量:3
  • 2张伯礼,王永炎.方剂关键科学问题的基础研究——以组分配伍研制现代中药[J].中国天然药物,2005,3(5):258-261. 被引量:159
  • 3王耘,史新元,乔延江.中药复杂性研究的内容与方法[J].中国天然药物,2005,3(5):262-265. 被引量:12
  • 4商洪才,李幼平,张伯礼.中医药临床疗效评价实践中的几点思考[J].天津中医药,2007,24(4):275-277. 被引量:23
  • 5Amidon G L, Lennem H, Shah V P, et al. A theoretical basis for a biopharmaceutics drug classification: the correlation of in v/tro drug product dissolution and in vivo bioavailahility [ J ]. Pharm Res,1995,12(3) :413.
  • 6Zhang J, Liu D, Huang Y, et al. Biopharmaeeutics classification and intestinalabsorption study of apigenin[ J]. Int J Pharm,2012, 436(1) :311.
  • 7Smetanova L, Stetinova V Kholova D, et al. Caco-2 ceils and biopharmaceutics classification system (BCS) for prediction of transepithelial transport of xenobiotics ( model drug: caffeine ) [J]. Neum Endocrinol Lett,2009,30:101.
  • 8Li I-I, Dong L, Liu Y, et al. Comparison of two approaches of in- testinal absorption by puerarin[ J]. J Pharmacol Toxicol Methods, 2014,25,70( 1 ) :6.
  • 9Li H, Dong L, Liu Y, et al. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats[ J]. Int J Pharm ,2014,15,466(1/2) : 133.
  • 10Keith C T, Borisy A A, Stoekwell B R. Muhicomponent thera- peutics for networked systems. [ J ]. Nat Rev Drug Discov,2005,4 (1) :71.

引证文献2

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部